This is an interesting article for HN. It's spun as a negative, using terms like "threatening", "monopoly", "controversial", and "retribution". You could write it the other way, where an immigrant-founded[1] startup is disrupting the mental health industry. Frankly, most of this seems like par for the course. Of course the company is seeking to push their product to market and commercial viability--and the potential…
did you read the article completely? there are 9 critics that worked with them, 6 ceased doing so. the company formed and closed it's non-profit venture and they are using typical pharma tactics, creating patents around it. spin is one thing but those facts do tell a story on it's own. > These experts are further troubled by the company’s business structure: Having first registered as a charity, Goldsmith and Malievs…
They definitely burned some bridges, but worse things happen all the time. The text you quoted even calls it "conventional pharmaceutical-industry tactics". Sounds like sour grapes to me.